Gene Symbol | CRP |
Entrez ID | 1401 |
Uniprot ID | P02741 |
Description | C-reactive protein, pentraxin-related |
Chromosomal Location | chr1: 159,712,289-159,714,589 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0006953 |
acute-phase response |
An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals. |
TAS |
BP |
GO:0006954 |
inflammatory response |
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
TAS |
BP |
GO:0008228 |
opsonization |
The process in which a microorganism (or other particulate material) is rendered more susceptible to phagocytosis by coating with an opsonin, a blood serum protein such as a complement component or antibody. |
TAS |
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IDA |
BP |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation |
Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions. |
IDA |
BP |
GO:0010888 |
negative regulation of lipid storage |
Any process that modulates the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. |
IDA |
BP |
GO:0032930 |
positive regulation of superoxide anion generation |
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell. |
IDA |
BP |
GO:0045908 |
negative regulation of vasodilation |
Any process that stops, prevents, or reduces the frequency, rate or extent of vasodilation. |
IDA|IMP |
BP |
GO:0050830 |
defense response to Gram-positive bacterium |
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
TAS |
BP |
GO:2000482 |
regulation of interleukin-8 secretion |
Any process that modulates the frequency, rate or extent of interleukin-8 secretion. |
IDA |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
NAS |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IDA |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
MF |
GO:0001849 |
complement component C1q binding |
Interacting selectively and non-covalently with the C1q component of the classical complement cascade. |
IDA |
MF |
GO:0005509 |
calcium ion binding |
Interacting selectively and non-covalently with calcium ions (Ca2+). |
IDA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0030169 |
low-density lipoprotein particle binding |
Interacting selectively and non-covalently with a low-density lipoprotein particle, a lipoprotein particle that is rich in cholesterol esters and low in triglycerides, is typically composed of APOB100 and APOE, and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. |
IDA |
MF |
GO:0033265 |
choline binding |
Interacting selectively and non-covalently with choline, the amine 2-hydroxy-N,N,N-trimethylethanaminium. |
TAS |
MF |
GO:0050750 |
low-density lipoprotein particle receptor binding |
Interacting selectively and non-covalently with a low-density lipoprotein receptor. |
IPI |
Domain ID | Description |
---|---|
IPR001759 |
Pentraxin-related |
IPR013320 |
Concanavalin A-like lectin/glucanase domain |
IPR030476 |
Pentaxin, conserved site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
WP1533 |
Vitamin B12 Metabolism |
WikiPathways |
WP15 |
Selenium Micronutrient Network |
WikiPathways |
WP3287 |
Overview of nanoparticle effects |
WikiPathways |
WP176 |
Folate Metabolism |
WikiPathways |
WP364 |
IL-6 signaling pathway |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0003469 |
Anxiety Disorders |
C0003873 |
Rheumatoid Arthritis |
C0004153 |
Atherosclerosis |
C0007222 |
Cardiovascular Diseases |
C0010346 |
Crohn Disease |
C0011854 |
Diabetes Mellitus, Insulin-Dependent |
C0011884 |
Diabetic Retinopathy |
C0018799 |
Heart Diseases |
C0018801 |
Heart Failure |
C0020503 |
Hyperparathyroidism, Secondary |
C0020538 |
Hypertensive Disease |
C0020557 |
Hypertriglyceridemia |
C0021368 |
Inflammation |
C0022661 |
Kidney Failure, Chronic |
C0023281 |
Leishmaniasis |
C0023290 |
Leishmaniasis, Visceral |
C0024121 |
Lung Neoplasms |
C0024141 |
Lupus Erythematosus, Systemic |
C0024530 |
Malaria |
C0025289 |
Meningitis |
C0025517 |
Metabolic Diseases |
C0027059 |
Myocarditis |
C0027707 |
Nephritis, Interstitial |
C0028754 |
Obesity |
C0031099 |
Periodontitis |
C0033860 |
Psoriasis |
C0038587 |
Substance Withdrawal Syndrome |
C0040053 |
Thrombosis |
C0085397 |
Pasteurellaceae Infections |
C0151744 |
Myocardial Ischemia |
C0311375 |
Arsenic Poisoning |
C0524620 |
Metabolic Syndrome X |
C0948089 |
Acute Coronary Syndrome |
C0993582 |
Arthritis, Experimental |
C1956346 |
Coronary Artery Disease |
C2239176 |
Liver Carcinoma |
C3714514 |
Infection |
Tissue | Cell Type |
---|---|
liver |
hepatocytes |
Database Name |
---|
DisGeNET |
DISEASES |
DGA |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
FCN2 |
2220 |
Q15485 |
0.56 |
HIST2H2AC |
8338 |
Q16777 |
0.56 |
CRP |
1401 |
P02741 |
0.62 |
MAPK3 |
5595 |
P27361 |
0.63 |
DGCR14 |
8220 |
Q96DF8 |
0.63 |
RPL13A |
23521 |
P40429 |
0.63 |
MAPK8IP2 |
23542 |
Q13387 |
0.63 |
GMPPA |
29926 |
Q96IJ6 |
0.63 |
C1QA |
712 |
P02745 |
0.75 |
APCS |
325 |
P02743 |
0.85 |
FCGR1A |
2209 |
P12314 |
0.52 |
FCGR2B |
2213 |
P31994 |
0.52 |
GP6 |
51206 |
Q9HCN6 |
0.52 |
LEP |
3952 |
P41159 |
0.55 |
HIST1H2AG; HIST1H2AI; HIST1H2AK; HIST1H2AL; HIST1H2AM |
8329 |
P0C0S8 |
0.55 |
HIST1H1A |
3024 |
Q02539 |
0.59 |
GLUD1 |
2746 |
P00367 |
0.63 |
MAPK1 |
5594 |
P28482 |
0.63 |
FCGR2C |
9103 |
P31995 |
0.63 |
LAMC3 |
10319 |
Q9Y6N6 |
0.63 |
SNRNP70 |
6625 |
P08621 |
0.73 |
FCGR2A |
2212 |
P12318 |
0.75 |
FN1 |
2335 |
P02751 |
0.75 |
CFH |
3075 |
P08603 |
0.76 |